期刊文献+

前列腺体积及前列腺穿刺针数对前列腺癌诊断的影响 被引量:5

The effect of prostate volume and prostate biopsy cores on the diction rate of prostate cancer
下载PDF
导出
摘要 目的探讨前列腺体积及前列腺穿刺针数对前列腺癌诊断情况的影响并分析其原因。方法回顾性总结2002∽2009年间于我院行超声引导下经直肠前列腺系统12针穿刺292例患者的临床资料。患者PSA在o~20ng/mL之间。经直肠超声计算前列腺体积。将患者按照前列腺体积分为:〈30mL,30∽60mL,60∽90mL,〉90mL四组,比较各组前列腺穿刺6针、8针、10针、12针时前列腺癌诊断率。统计学Fisher’S检验比较各组间差异性。结果总体前列腺癌诊断率为25%(73/292),在〈30mL组:6针、8针、10针、12针的前列腺癌诊断率相同,均为39.13%(21/54);在30~60mL组:6针、8针、10针、12针的诊断率分别为:21.3%(23/108)、23.1%(25/108)、23.1%(25/108)、24.1%(26/108),诊断率无显著差异(P〉0.05)。在60~90mL组:6针的诊断率为12.9%(12/93),显著低于8针(19.4%(18/93)3、10针[20.4%(19/93)]、12针(20.4%(19/93)]的诊断率(Pd0.05)。在〉90mL组:6针、8针的诊断率均为8.1%(3/37),显著低于10针、12针的诊断率C18.9%(7/37),P〈0.053。黠论前列腺体积是选择前列腺穿刺针数时的一个重要的参考因素,在前列腺体积较大的情况下,可适当的增加前列腺穿刺针数,在前列腺体积较小的情况下,增加前列腺穿刺针数并不能提高前列腺癌的诊断率。 Objective To investigate the relationship between prostate volume, prostate biopsy cores and Pca detection rate. Melhods A total of 292 patients with PSA between 0 and 20 ng/mL and/or abnormal DRE underwent 12 ∽ core prostate biopsy from Jan. 2002 to Dec. 2009. Prostate volume was detected with transrectal ultrasound. All patients were divided into ∽30 mL, 30∽60 mL, 60∽90 mL, and 990 mL groups according to prostate volume. And then the Pca detection rates of 6∽, 8∽, 10∽ and 12∽ core protocols in each group were compared. Rest/Its The total Pca detection rate was 25.0% (73/292). In ∽ 30 mL group, Pca detection rates were the same for each protocol (39.13%, 21/54). In 30∽60 mL group, Pea detection rates of 6∽ core (21.3%, 23/108), 8∽ core (23.1%, 25/108), 10∽ core (23.1%, 25/108) and 12∽ core (24. 1%, 26/108) were not significantly different (P〉0. 05). In 60∽ 90 mL group, 6∽core (12.9%, 12/93) protocol had significantly lower Pca detection rate (P〈0.05) than. 8∽core (19.4%, 18/93), 10~ core (20.4%, 19/93), 12∽ core (20.4%, 19/93) protocols. In ∽90 mL groups, Pea detection rates of 6∽ core (8. 1%, 3/37), 8∽ core (8.1%, 3/37) protocols were significantly lower (P〈0.05) than 10∽ core (18. 9%, 7/37), 12∽ core (18.9%, 7/37) protocols. Conclt/sions Prostate volume can be an important index for the choice of core. Increased cores will not improve Pca detection rate if the vrostate volume is not be considered.
出处 《现代泌尿外科杂志》 CAS 2011年第4期352-354,共3页 Journal of Modern Urology
关键词 前列腺体积 穿刺活检 前列腺癌 发病率 prostate volume prostate cancer prostate biopsy morbidity
  • 相关文献

参考文献11

  • 1O'UNG J, IGNACIO F, FRANCISCO S, et al. The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection[J]. J Urol,2003,169(1):130.
  • 2YILMAZ S, ESKICORAPCI, GULIYEV F, et al. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection[J]. JUro1,2005,173(5) : 1536.
  • 3AL-AZAB R, TOI A, LOCKWOOD GINA. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen calues between 2. 0 and 9.0 ng/mL[J]. Urology, 2007,69(1)103-107.
  • 4ELABBADY AA, KHEDR MM. Extended 12-core prostate biopsy increases both the detection of prostate cancer and theaccuracy of Gleason score[J]. Eur Urol,2006,49:49-53.
  • 5SINGH H, CANTO EL, SHARIAT SF, et al. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy [J]. J Urol, 2004, 171 ( 3 ):1089-1092.
  • 6BORBOROGLU PG, COMER SW, RIFFENBURGH RH, et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies[J]. JUrol, 2000,163(1):158-162.
  • 7STEWART CS, LEIBOVICH BC, WEAVER AL, et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies[J]. J Urol,Z001,166(1)86-91.
  • 8CHANG YL, ALEX T, LI L, et al. Correlation between serum prostate specific antigen and prostate volume in Taiwan Residents men with biopsy proven benign prostatic hyperplasia[J]. J Urol, 2006,175(1):196.
  • 9VINCENZO F, GIOVANNI N, GIACOMO N, et al. The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy[J]. Euro Uro, 2005,48(6):932-937.
  • 10SHIM HB, PARK HK, LEE SE. Optimal site and number of biopsy cores according to prostate volume prostate cancerdetection in korea[J]. Urology, 2007,69(5) ~ 902-906.

同被引文献76

  • 1梁朝朝,陈先国,周骏,江长琴.前列腺癌治疗中应该重视的几个问题[J].中华临床医师杂志(电子版),2011,5(18):5256-5258. 被引量:6
  • 2陈国新.经直肠超声在前列腺增生及前列腺癌诊断中的应用[J].右江民族医学院学报,2006,28(3):471-472. 被引量:1
  • 3Hodge KK, McNeal JE, Terris MK, et al. Random sys- tematic versus directed ultrasound guided transrectal core biopsies of the prostate[J]. J UroI, 1989,142(1):71-74.
  • 4Lukes M, Urban M, Zalesky M, et al. Prostate-specific antigen., current tatus [J ]. Folia Biol (Praha), 2001,47 (2) :41-49.
  • 5Ishidoya S,Ito A, Orikasa K, et al. The outcome of pros- tate cancer screening in a normal Japanese population with PSA of 2-4 ng/ml and the free/total PSA under 12%[J]. Jpn J Clin Oncol,2008,38 (12) :844-848.
  • 6Gilbert SM, Cavallo CB, Kahane H, el al. Evidence sug- gesting PSA outpoint of 2.5 ng/mL for prompting pros- tate biopsy: review of 36.316 biopsies[J].Urology, 2005, 65(3) : 549-553.
  • 7Stewart CS, Leibovich BC, Weaver AL, et al. Prostate cancer diagnosis using a saturation needle biopsy tech- nique aftel previous negative sextantbiopsies[J].J Urol, 2001,166(1) : 86-91.
  • 8Djavan B, Remzi M, Marberger M. When to biopsy and when to stop biopsying[J]. Urol Clin North Am, 2003, 30(2) :253-262.
  • 9Igel TC,Knight MK, Young PR,et al. Systematie trans- perineal ultrasound guided template biopsy of the pros- tate in patients at high risk[J].J Urol, 2001,165 (5) : 1575-1579.
  • 10Campodonico F, Casarieo A,G avazzi L,et a[. Cancer de- tection with TRUS-guided 10-core biopsy of the pros- tate. an institutional assessment at the first, repeated and surgical specimen biopsy[J]. Arch I tal Urol Androl, 2006,78(2) :39-43 .

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部